We remain committed to providing strong protection for the significant global patient population affected by venous thromboembolic
disease," commented Lindsay L.
His meta-analysis demonstrated lower risks of thromboembolic
and cerebrovascular events with anastrozole and letrozole, compared with tamoxifen, but higher rates of hypercholes-terolemia and coronary heart disease.
Patients taking Avastin (bevacizumab) may be at a higher risk for serious arterial thromboembolic
events, according to the Food and Drug Administration.
Six of these patients had a symptomatic thromboembolic
event confirmed within the next 3 months (2 had a nonfatal PE and 4 had DVT), yielding a symptomatic complication rate of 0.
In contrast, the venous thromboembolic
rate in statin users randomized to receive placebo was 0.
Food and Drug Administration (FDA) granted marketing approval of ATryn, developed through recombinant technology, for the prevention of peri-operative and peri-partum thromboembolic
events in patients with hereditary antithrombin deficiency (HD AT), a rare and potentially fatal blood clotting disorder.
A warfarin regimen that keeps a patient in the INR target range less than half the time "is no better than placebo," and may actually harm patients by causing an excess of thromboembolic
events or intracranial hemorrhages, said Dr.
BACKGROUND In the middle of the last decade several studies suggested an increased risk of thromboembolic
events in women using the newer generation of oral contraceptives (OCs).
Chapter 6 Plasma D-Dimer and Venous Thromboembolic
The guideline was updated to include recommendations regarding the use of darbepoetin alfa, which came to market after epoetin alfa, and to address risks of thromboembolic
events associated with the use of both agents.
The occurrence of an idiopathic thromboembolic
event in an elderly patient is associated with an increased risk of being diagnosed with colon cancer within the next 2 years, Dr.
Other outcomes measured included bone density, nonvertebral fractures, breast and endometrial cancer, thromboembolic
disease, and other adverse events.